Periodic Reporting for period 1 - EDUC8 (Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity)

The development of anti-drug antibodies is the major complication of treatment with biotherapeutics. This is particularly true of patients with haemophilia A (HA) who develop neutralizing antibodies to therapeutic factor VIII (FVIII) following replacement therapy with...